Prevention and treatment of congenital toxoplasmosis: Organization protocol;Prevenzione e trattamento della toxoplasmosi congenita: Modello organizz̀ativo

Minerva Ginecologica

Volumn 56, Issue 2, 2004, Pages 171-178

  Vimercati, A ^a   Angelici, M C ^b   De Cosmo, L ^a   Doria, G ^a   Cuccovillo, A R ^a   Lezzi, V ^a   Nigro, A ^a   Lucaselli, R ^a   Pontrelli, G ^a   Selvaggi, L ^a  

^a UNIVERSITY OF BARI   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Prenatal diagnosis; Toxoplasmosis, congenital, diagnosis; Toxoplasmosis, congenital, therapy

Indexed keywords

FOLINIC ACID; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PYRIMETHAMINE SULFADIAZINE; SPIRAMYCIN;

AMNION FLUID ANALYSIS; ARTICLE; CASE REPORT; CLINICAL PROTOCOL; CONGENITAL TOXOPLASMOSIS; COOPERATION; FOLLOW UP; HEALTH CARE DELIVERY; HUMAN; ITALY; MATERNAL DISEASE; NEWBORN; OUTCOMES RESEARCH; OUTPATIENT CARE; PATIENT REFERRAL; PRACTICE GUIDELINE; PRENATAL DIAGNOSIS; SEROCONVERSION;

CLINICAL PROTOCOLS; HUMANS; MODELS, THEORETICAL; RISK FACTORS; TOXOPLASMOSIS, CONGENITAL;

EID: 3042641214     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Foulon W, Villena I, Stray-Pedersen B, Decoster A, Lappalaienen M, Pinon JM et al. Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year. Am J Obstet Gynecol 1999;180:410-5.
2. Gras L, Gilbert R, Ades A, Dunn D. Effect of prenatal treatment on the risk of intracranial and ocular lesions in children with congenital toxoplasmosis. Int J Epidemiol 2001;30:1309-13.
3. Guerina NG, Hsu HW, Meissner C, Maigure JH, Lynfield R, Stechenberg B et al. Neonatal serologic screening and early treatment for congenital toxoplasma gondii infection. N Engl J Med 1994;330:1858-63.
4. Vimercati A, Greco P, D'Apolito A, Angelici MC, Possenti A, Carbonara S et al. Valutazione del rischio di trasmissione verticale dell'infezione da toxoplasma. Acta Bio-Medica de "L'ateneo Parmense" 2000;71:537-40.
5. Vimercati A, Greco P, Angelici MC, Cuccovillo AR, Lezzi V, De Cosmo L et al. Screening, diagnosi prenatale e trattamento della toxoplasmosi congenita: Controversie ancora aperte. Cento (FE): Edit Symposia Ginecologica; 2002.
6. Greco P, Vimercati A, Angelici MC, Carbonara S, Doria G, Selvaggi L. Toxoplasmosis in pregnancy is still an open subject. J Perinat Med 2003;31:36-40.
7. Zotti C, Garella D, Moiraghi Ruggenini A et al. Infezione da Toxoplasma Gondii e gravidanza. Ossenazioni relative a epidemiologia, diagnosi e prevenzione. Min Gin 1985;37:671-6.
8. Angelici MC, Buffolano W, Grandolfo M, Gramiccia M, Majori G. Il controllo della toxoplasmosi congenita in Italia: il progetto dell'Istituto Superiore di Sanità. Ann Ist Super Sanità 1999;35:329-33.
9. Pedrera DAL, Camargo ME, Leser PG. Toxoplasmosis: will the time ever come? Ultrasound Obstet Gynecol 2001;17:459-63.
10. Wallon M, Liou C, Garner P, Peyron F. Congenital toxoplasmosis: systematic review of evidence of efficacy of treatment in pregnancy. BMJ 1999;318:1511-14.
11. Lebech M, Andersen O, Christensen NC, Hertel J, Nelsen HE, Peedersen B et al. Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Lancet 1999;353:1834-37.
12. Grover CM, Thulliez P, Remington JS, Boothroyd JC. Rapid prenatal diagnosis of congenital toxoplasma infection by using PCR and amniotic fluid. J Clin Micro 1990;28:2297-301.
13. Hohlfeld P, Daffos F, Costa JM, Thulliez P, Forestier F, Vidaud M. Prenatal diagnosis of congenital toxoplasmosis with a PCR test on amniotic fluid. N Engl J Med 1994;331:695-99.
14. Gratzl R, Hayde M, Kohlhauser C, Hermon M, Burd G, Strobl W et al. Follow-up of infants with congenital toxoplasmosis by PCR analisys of amniotic fluid. Eur J Clin Micro Infect Dis 1998;17:853-58.
15. Lebech M, DHM Joynson, HM Seitz, P Thulliez, RE Gilbert, GN Dutton et al. Classification system and case definitions of toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. Eur J Clin Microbiol Infect Dis 1996;15:799-805.
16. Hedman K, Lappalainan M, Seppaia E, Makela O. Recent primary toxoplasma infection indicated by a low avidity of specific IgG. J Infect Dis 1989;59:736-40.
17. Joynson DHM, Payne RA, Rawel BK. Potential role of IgG avidity for diagnosing toxoplasmos. J Clin Pathol 1990;43:1032-3.
18. Marini A, Rondini G, Salvioli GP et al. Proposta di linee guida per la diagnosi di toxoplasmosi congenita. Pediatr Neonatol Rev 1998;1:19-24.